ResearcherSeoul National UniversityActive in the last 2 years

Seong‐Jin Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4335-8793; OpenAlex author ID A5100321814. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wooil Kwon · 2 shared papers, 2019–2026 · strength 0.30
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗
Eunsung Jun · 1 shared paper, 2025 · strength 0.27
- Paper Cetuximab-mediated antibody-dependent cell-mediated cytotoxicity enhances anti-tumor efficacy of patient-derived natura… DOI 10.1016/j.biopha.2025.118714 ↗
EunJi Kim · 1 shared paper, 2025 · strength 0.27
- Paper Cetuximab-mediated antibody-dependent cell-mediated cytotoxicity enhances anti-tumor efficacy of patient-derived natura… DOI 10.1016/j.biopha.2025.118714 ↗
Song Cheol Kim · 1 shared paper, 2025 · strength 0.27
- Paper Cetuximab-mediated antibody-dependent cell-mediated cytotoxicity enhances anti-tumor efficacy of patient-derived natura… DOI 10.1016/j.biopha.2025.118714 ↗
Eunji Hong · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Ja‐Lok Ku · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Toshikazu Ushijima · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Daechan Park · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Seon Ah Lim · 1 shared paper, 2019 · strength 0.08
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗
Kyung‐Mi Lee · 1 shared paper, 2019 · strength 0.08
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗
Cassian Yee · 1 shared paper, 2019 · strength 0.08
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗
Jin‐Young Jang · 1 shared paper, 2019 · strength 0.08
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗
Sun‐Whe Kim · 1 shared paper, 2019 · strength 0.08
- Paper Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Canc… DOI 10.3389/fimmu.2019.00496 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.